Cadila, Aurobindo, Torrent get licence to make generic version of Pfizer’s oral COVID medication
The companies have received the nod after inking a sub-licensing pact with Medicines Patent Pool (MPP), a UN-based public health organisation working to increase access to life-saving medicines for low- and middle-income countries. Leading drug makers Cadila Pharmaceuticals, Aurobindo Pharma and Torrent Pharmaceuticals on Thursday said they have received a licence to manufacture a generic … Read more